Switch View
© Newsfile
14.11.2025
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Winlevi(R) Receives Regulatory Approval in Brazil - Expanding Global Access to a Breakthrough Acne Treatment
News Preview
Dublin, Ireland--(Newsfile Corp. - November 14, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and dermatology innovations, today announced that the Brazilian Health Regulatory Agency (ANVISA) has approved Winlevi® (clascoterone) cream 1% for the treatment of acne vulgaris in patients aged tw...
Themefolio
Profiler
Peergroup
© EQS Newswire
14.11.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Strong sales and earnings growth in local currencies, outperforming the market
News Preview
Group Media & Investor ReleaseAd hoc announcement pursuant to Art. 53 LR
Staefa (Switzerland), November 14, 2025 – Sonova Holding AG (SWX: SOON), a leading provider of innovative hearing solutions, today announces results for the first half of its 2025/26 financial year.
Group sales reached CHF 1,815.4 million, up 4.9% in local currencies. Th......
Themefolio
Profiler
Peergroup
© EQS Newswire
14.11.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Starkes Umsatz- und Gewinnwachstum in Lokalwährungen, deutlich über dem Markt
News Preview
Group Media & Investor ReleaseAd hoc-Mitteilung gemäss Art. 53 KR
Stäfa (Schweiz), 14. November 2025 – Die Sonova Holding AG (SWX: SOON), ein führender Anbieter innovativer Hörlösungen, gibt heute das Ergebnis für das erste Geschäftshalbjahr 2025/26 bekannt.
Der Gruppenumsatz erreichte CHF 1’815,4 Mio., was einem Anstieg von 4,9% in Lokalwähru......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
14.11.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Obtient des Engagements de Financement pouvant atteindre U.S. $77 Millions pour Supporter la Commercialisation de Genio aux États-Unis
News Preview
INFORMATIONS PRIVILÉGIÉESINFORMATIONS RÉGLEMENTÉES...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
14.11.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Interim Report - January-September 2025
News Preview
STOCKHOLM – 14 November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
News Preview
COPENHAGEN, Denmark, November 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2025 and business progress for the third quarter of 2025....
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the "Class Period") of the important December 29, 2025 lead plaintiff deadline.SO WHAT: If you pur...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
ISIN: CA31447P1009
Fennec Pharmaceuticals Inc
FRX
LISTED
TSX
Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada
News Preview
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that it intends to engage in a non-brokered offering of its common shares in Canada, at a price of US$7.50 per share, with certain of its existing inst...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
ISIN: CA31447P1009
Fennec Pharmaceuticals Inc
FRX
LISTED
TSX
Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares
News Preview
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the pricing of its underwritten registered public offering of 4,666,667 common shares at a public offering price of $7.50 per share. In addition, Fenne...
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOH
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline.SO WHAT: If you pu...
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline.SO WHAT: If you pu...
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR RIGHTS COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - JSPR
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.SO WHAT...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
14.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi pa...
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
ROSEN, A RANKED AND LEADING FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline.SO WHAT...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – DXCM
News Preview
The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of DXCM during the class p...
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the inve...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
News Preview
INSIDE INFORMATIONREGULATED INFORMATION...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit ha...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
News Preview
TOKYO and CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQ...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Far...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Reports Third Quarter 2025 Financial Results and Highlights Recent Updates
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter 2025 financial results and highlighted recent corporate updates.
“We significantly advanced our NGN-401 gene therapy clinical program for Rett synd...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
News Preview
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies, Inc. (NASDAQ: IRTC).
If you currently own shares of iRhythm stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=22399 for more information...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
December 29, 2025 Deadline Approaching: Join Class Action Against Avantor, Inc. (AVTR) - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Avantor, Inc. (NYSE: AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=177271&wire=5&utm_campaign...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Deadline Soon: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 17, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, i...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
Investors in Tvardi Therapeutics, Inc. (TVRD) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ: TVRD) concerning possible violations of federal securities laws.On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZIMMER BIOMET HOLDINGS, INC. (ZBH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Law Offices of Howard G. Smith Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintif...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk A/S: Candidate for the Board of Directors will not seek election
News Preview
Today, it was announced that Mikael Dolsten will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead plaintiff deadline.SO WHAT: If you purchase...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
News Preview
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet Reports Third Quarter 2025 Financial Results
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet’s Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results a...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.11.2025
ISIN: DK0011048619
BioPorto A/S
BIOPOR
LISTED
CPH
Private placement of 40,438,426 new shares fully subscribed – gross proceeds of approximately DKK 43 million to BioPorto A/S
News Preview
13 November 2025...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
